Osaic Holdings
AVBP icon

Osaic Holdings’s ArriVent BioPharma AVBP Stock Holding History

Osaic Holdings’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.2K Buy
1,378
+676
+96% +$20.7K ﹤0.01% 5649
2026
Q2 		$24.4K Hold
702
– – ﹤0.01% 6021
2026
Q1 		$16.2K Buy
702
+106
+18% +$2.39K ﹤0.01% 5997
2025
Q4 		$12K Buy
596
+118
+25% +$2.46K ﹤0.01% 6225
2025
Q3 		$8.82K Buy
478
+309
+183% +$6.07K ﹤0.01% 6443
2025
Q2 		$3.38K Buy
+169
New +$3.51K ﹤0.01% 6746
2025
Q1 		– Sell
-17
Closed -$453 – 7743
2024
Q4 		$453 Buy
+17
New +$488 ﹤0.01% 7039

Other funds holding AVBP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HSG Holding
HSG Holding Na, Hong Kong $1.26B AUM 34.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Osaic Holdings's AVBP Position: Q3 2026 in Review

Osaic Holdings increased its ArriVent BioPharma (AVBP) stake by 96% in Q3 2026, buying an estimated $20.7K and bringing the position to 1,378 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5649.

Osaic Holdings first reported a position in AVBP in Q4 2024 and has held it in 7 quarters since. 96 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Osaic Holdings held 1,378 shares of ArriVent BioPharma worth $41.2K as of Q3 2026.
  • Osaic Holdings bought 676 ArriVent BioPharma shares in Q3 2026, an estimated $20.7K.
  • ArriVent BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5649 holding.
  • Osaic Holdings first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 96 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.